ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2020
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
ResMed (RMD) Tops Q3 EPS by 25c, Revenues Beat
April 30, 2020 4:44 PM EDTResMed (NYSE: RMD) reported Q3 EPS of $1.29, $0.25 better than the analyst estimate of $1.04. Revenue for the quarter came in at $769.5 million versus the consensus estimate of $722.52 million.
Third Quarter 2020 Highlights
Year-over-year revenue grows 16%, non-GAAP operating profit up 31%Balanced growth across product portfolio, software solutions, and global marketsFocused on combating COVID-19 pandemic through increased ventilator production and ongoing partnership and support of key global stakeholdersAll comparisons are to the prior-year period
Revenue increased 16% to $769.5 million; up 17% on a constant currency basisGAAP... More